In vitro and preclinical assessment of factorial design based nanoethosomes transgel formulation of an opioid analgesic

References

• Ahad A, Aqil M, Ali A. 2014. Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1, 8-cineole. Int J of Bio Macromol. 64:144–149.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. 2011. Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride. Curr Drug Del. 8:213–224.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. 2013. Enhanced transdermal delivery of an antihypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. Int J of Pharm. 443:26–38.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, SultanaY, Mujeeb M, Ali A. 2012. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomed. 8:237–249.
   PubMed Web of Science ®Google Scholar
• Ameeduzzafar, Ali J, Khan N, Ali A. 2014. Development and optimization of carteolol loaded corboxymethyl tamarind kernel polysaccharide nanoparticles for ophthalmic delivery: Box-Behnken design, in vitro, ex vivo assessment. Sci Adv Mat. 6:1–13.
   Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, Kamel R. 2009. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: physicochemical evaluation. AAPS Pharm Sci Tech. 1:7–20.
   Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, Kamel R. 2009. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part II: biological evaluation. AAPS Pharm Sci Tech. 10:1065–1070.
   PubMed Web of Science ®Google Scholar
• Beg S, Sandhu PS, Batra RS, Khurana RK, Singh B. 2014. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Deliv. 22: 765–784.
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Kohli K, Amin S, Permender R, Vikash K. 2009. Optimization and formulation design of gels of diclofenac and curcumin for transdermal drug delivery by Box-Behnken statistical design. J of Pharm Sci. 100:580–593.
   Web of Science ®Google Scholar
• Chaudhary H, Kohli K, Vikash K. 2014. A novel nano-carrier transdermal gel against inflammation. Int J of Pharm. 465:175–186.
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Rohilla A, Rathee P, Kumar V. 2013. Optimization and formulation design of carbopol loaded Piroxicam gel using novel penetration enhancers. Int J of Biol Macromol. 55:246–253.
   PubMed Web of Science ®Google Scholar
• Csoka G, Marton S, Zelko R, Otomo N, Antal I. 2007. Application of sucrose fatty acid esters in transdermal therapeutic systems. Eur J of Pharm and Biopharm. 65:233–237.
   PubMed Web of Science ®Google Scholar
• Dayan N, Touitou E. 2000. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials. 21:1879–1885.
   PubMed Web of Science ®Google Scholar
• Draize J, Woodward G, Calvery H. 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J of Pharmacol and Exp Therap. 82:377–389.
   Web of Science ®Google Scholar
• Dua, K, Chakravarthi, S, Kumar, D, Sheshala, R, Gupta, G. 2013. Formulation, characterization, in vitro, in vivo, and histopathological evaluation of transdermal drug delivery containing norfloxacin and Curcuma longa. Int J Pharm Investig. 3:183–187.
   PubMedGoogle Scholar
• Dubey V, Mishra D, Jain NK. 2007. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J of Pharm and Biopharm. 67:398–405.
   PubMed Web of Science ®Google Scholar
• Govender S, Pillay V, Chetty DJ, Essack SY, Dangor CM, Govender T. 2005. Optimization and characterization of bioadhesive controlled release tetracycline microspheres. Int J of Pharm. 306:24–40.
   PubMed Web of Science ®Google Scholar
• Higuchi T. 1963. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J of Pharm Sci. 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Imam SS, Aqil M, Akhtar M, Sultana Y, Ali A. 2014. Formulation by designbased proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Deliv. 1 -12. DOI: 10.3109/10717544.2013.870260.
   Google Scholar
• Keyao A, Sun Y, Xu L, Cui X. 2011. Preparation and in vitro evaluation of simvastatin ethosome. Artif Cells Blood Substit Immobil Biotechnol. 39:347–350.
   PubMed Web of Science ®Google Scholar
• Keyao A, Yong Sun Y, Yan Wu Y, Haicheng Yuan H, Zhaoyuan Cui Z, Xu L. 2013. Preparation and in vitro percutaneous penetration of simvastatin ethosome gel. Artif Cells Nanomed Biotechnol. 41:315–318.
   PubMed Web of Science ®Google Scholar
• Komatsu H, Okada S. 1996. Ethanol enhanced permeation of phosphatidyl choline/phosphatidylethanolamine mixed liposomal membranes due to ethanol induced lateral phase separation. Biochim Biophys Acta. 1283:73–79.
   PubMed Web of Science ®Google Scholar
• Magnusson BM, Runn P, Karlsson K, Koskinen L. 1997. Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis. Int J Pharm. 157:113–121.
   Web of Science ®Google Scholar
• Mura S, Manconi M, Sinico S, Valenti D, Fadda, AM. 2009. Penetration enhancer containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J of Pharm. 380:72–79.
   PubMed Web of Science ®Google Scholar
• O’Neill KA. 1983. An automated, high-capacity method for measuring jump latencies on a hot plate. J of Pharmacol Meth. 10:13–18.
   PubMedGoogle Scholar
• Rhee Y, Chang S, Park E. 2008. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration. Int J of pharm. 364:14–20.
   PubMed Web of Science ®Google Scholar
• Rosenblum A, Marsch LA, Joseph H, Portenoy RK. 2008. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp and Clin Psychopharm. 16:405–416.
   PubMed Web of Science ®Google Scholar
• Singh B, Kumar R, Ahuja N. 2005. Optimizing drug delivery systems using systematic design of experiments Part I: Fundamental aspects. Crit Rev in Ther Drug Carrier Sys. 22:27–105.
   PubMed Web of Science ®Google Scholar
• Tait RC, Chibnall JT, Krause S. 1990. The pain disability index: psychometric properties. Pain. 40:171–182.
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Murthy TK, Pai MR, Mehta PR, Chowdary PB. 2003. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS Pharm Sci Tech. 4:1–6.
   Google Scholar
• Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. 2000. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J of Cont Rel. 65:403–418.
   PubMed Web of Science ®Google Scholar
• Verma P, Pathak K. 2010. Therapeutic and cosmeceutical potential of ethosomes: an overview. J of Adv Pharm Tech Res. 1:274–282.
   PubMedGoogle Scholar
• Woolfe G, MacDonald AD. 1944. The evaluation of the analgesic action of pethidine hydrochloride. J of Pharmac Exp Ther. 80:300–307.
   Google Scholar
• Yalda HA, Mohammad-Reza R. 2007. Improved liquid chromatographic method for the simultaneous determination of tramadol and its three main metabolites in human plasma, urine and saliva. J of Pharm Biomed Anal. 44:1168–1173.
   PubMed Web of Science ®Google Scholar